s6y PetLife Pharmaceuticals, Inc. 10-K

PetLife Pharmaceuticals, Inc. 10-K, filed Dec 21, 2016: IDEA: XBRL DOCUMENT

Going Concern (Details Narrative) - USD ($)
Aug. 31, 2016
Aug. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 7,131,330 $ 3,444,290